Search Filters

Search Results

Found 3 results

510(k) Data Aggregation

    K Number
    K140805
    Device Name
    ITCLAMP 50
    Date Cleared
    2014-10-09

    (191 days)

    Product Code
    Regulation Number
    870.4450
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The iTClamp50 is a trauma clamp device for the temporary control of severe bleeding in the extremities, axilla, inguinal areas, scalp, and neck.

    Device Description

    The iTClamp™50 is a clamp device that quickly controls critical bleeding by closing the skin to create a temporary, contained hematoma until surgical repair. The iTClamp50 is a selflocking surgical clamp with suture needles that penetrate the skin to evert the skin edges (similar to sutures or staples) between pressure bars of the device and anchor it to the skin to reduce slippage and leakage. Pressure is evenly distributed across the bars, which seal the skin over a wound. An adjustable locking mechanism increases or decreases pressure across the wound to achieve a fluid tight seal.

    The iTClamp controls bleeding by sealing the skin closed to apply direct pressure to the cut edges of the skin and create a temporary pool of blood (hematoma) under pressure. This permits formation of a stable clot until the patient can receive medical care and/or surgical repair.

    The device is provided sterile and is for single use.

    The iTClamp consists of the following components:

      1. Suture needles
      1. Plastic shell
      1. Locking mechanism
      1. Lock release mechanism
    AI/ML Overview

    The provided text describes a 510(k) premarket notification for the iTClamp50, a vascular clamp device. The purpose of this 510(k) is to modify the existing indication for use to include the temporary control of severe bleeding in the neck.

    Here's an analysis of the acceptance criteria and the study that proves the device meets them, based on the provided text:

    Acceptance Criteria and Reported Device Performance

    The acceptance criteria are implicitly tied to demonstrating substantial equivalence for the expanded indication of use (neck wounds). The previous 510(k) (K132651) established the device's efficacy for extremities, axilla, inguinal areas, and scalp. For this new 510(k), the key performance aspect is the device's ability to control severe bleeding in the neck.

    Acceptance Criterion (Implicit)Reported Device Performance
    Safety: BiocompatibilityMet: No additional biocompatibility testing was deemed necessary. The physical composition, sterilization, and packaging have not changed, so the testing from K132651 is applicable.
    Performance: Bench testing (mechanical integrity, fluid seal)Met: No additional bench performance testing was deemed necessary. The physical composition, packaging, and sterilization have not changed. Bench testing from K132651 is applicable.
    Performance: Efficacy in controlling bleeding in neck woundsMet (via cadaver studies and case studies): Innovative Trauma Care performed cadaver testing to demonstrate the suitability of the iTClamp50 for neck wounds. A second cadaver study compared the iTClamp50's performance with standard of care (direct manual pressure and balloon catheter inflation) and concluded that the device is suitable for neck use and substantially equivalent to the previous 510(k). Additionally, unsolicited case studies from OUS (Outside the US) and off-label use provided supportive data on the device's performance for treating neck wounds.
    Usability/User Proficiency: Proper application and removalMet: A user assessment involving 15 trained first responders (firefighters) was previously conducted for K132651 using a bleeding arm simulator model. This assessment found that training based on the DFU provided sufficient information for successful application and removal, with a needle stick occurrence of
    Ask a Question

    Ask a specific question about this device

    K Number
    K132651
    Device Name
    ITCLAMP 50
    Date Cleared
    2013-10-28

    (63 days)

    Product Code
    Regulation Number
    870.4450
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The iTClamp50 is a trauma clamp device for the temporary control of severe bleeding in the extremities, axilla, inguinal areas and scalp.

    Device Description

    The iTClamp™50 is a clamp device that quickly controls critical bleeding by closing the skin to create a temporary, contained hematoma until surgical repair. The iTClamp50 is a selflocking surgical clamp with suture needles that penetrate the skin to evert the skin/scalp edges (similar to sutures or staples) between pressure bars of the device and anchor it to the skin to reduce slippage and leakage. Pressure is evenly distributed across the bars, which seal the skin over a wound. An adjustable locking mechanism increases or decreases pressure across the wound to achieve a fluid tight seal. The iTClamp controls bleeding by sealing the skin/scalp closed to apply direct pressure to the cut edges of the skin/scalp and create a temporary pool of blood (hematoma) under pressure. This permits formation of a stable clot until the patient can receive medical care and/or surgical repair. The device is provided sterile and is for single use. The iTClamp consists of the following components: 1) Suture needles 2) Plastic shell 3) Locking mechanism 4) Lock release mechanism

    AI/ML Overview

    Here's an analysis of the provided text regarding the iTClamp™50 device, specifically focusing on the acceptance criteria and study details:

    The provided document is a 510(k) summary for the iTClamp™50, seeking to expand its indication for use to include the scalp. It is not a study proving the device meets acceptance criteria in the typical sense of a clinical trial or a performance study with defined, measurable endpoints for regulatory acceptance. Instead, it argues for "substantial equivalence" to predicate devices based on design, operation, and a cadaver study for the expanded indication.

    Therefore, many of the requested fields (like specific acceptance criteria for performance metrics, sample sizes for test sets in a clinical context, expert ground truth, MRMC studies, or training sets) are not directly applicable or explicitly stated in a quantitative manner as they would be for a new or significantly modified device requiring rigorous performance evaluation.


    1. Table of Acceptance Criteria and Reported Device Performance

    As this is a 510(k) for an expanded indication based on substantial equivalence, explicit quantitative acceptance criteria for device performance (e.g., a specific percentage reduction in blood loss, time to hemostasis within a certain threshold) are not defined in the provided text. The "acceptance" argument is qualitative and based on the device's ability to effectively control bleeding on the scalp in a cadaver model, aligning with the predicate device's function.

    Acceptance Criteria (Implied)Reported Device Performance (Summary)
    Safe for use on the scalpCadaver study identified no additional risks.
    Effective in controlling severe bleeding on the scalp (hemostasis)Cadaver study demonstrated effectiveness and safety on the scalp.
    Performs as intendedCadaver study ensured the device performed as intended; results indicate suitability for use on the scalp.
    Substantially equivalent to predicate devices for scalp usePerforms similarly to predicate devices by applying pressure to control bleeding on scalp wounds.

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size: Not explicitly stated as a number of subjects or cases. The study used "cadaver models" which implies a limited number for this type of testing.
    • Data Provenance: The study was conducted by Innovative Trauma Care, Inc. using cadaver models. There is no mention of country of origin for the cadaver data. The study is prospective in the sense that the testing was performed specifically to support this 510(k) submission, even if it utilized cadavers.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    • Number of Experts: Not specified.
    • Qualifications of Experts: Not specified. It's likely that medical professionals or researchers involved in the cadaver study would have assessed the outcomes, but their specific roles or qualifications are not detailed.

    4. Adjudication Method for the Test Set

    • The document does not describe any formal adjudication method (e.g., 2+1, 3+1 consensus) for the cadaver study results.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs Without AI Assistance

    • No MRMC comparative effectiveness study was done. This is a medical device (vascular clamp), not an AI-assisted diagnostic tool, so this type of study is not relevant or applicable.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    • Not applicable. This is a physical medical device, not an algorithm. Its performance is inherent in its design and how it's used by a human clinician. The cadaver study implicitly describes the standalone device's performance when applied.

    7. The Type of Ground Truth Used

    • For the cadaver study, the "ground truth" would be the observed effectiveness of hemostasis (stopping bleeding) in the cadaver models, assessed directly by the researchers. It's an observational outcome within the cadaveric setting. There is no mention of pathology or broader patient outcomes data for the cadaver study.

    8. The Sample Size for the Training Set

    • Not applicable. This is a physical medical device, not an algorithm or AI system that requires a "training set."

    9. How the Ground Truth for the Training Set Was Established

    • Not applicable. As there is no training set for a physical device, no ground truth needs to be established for it.
    Ask a Question

    Ask a specific question about this device

    K Number
    K123551
    Device Name
    ITCLAMP 50
    Date Cleared
    2013-05-14

    (176 days)

    Product Code
    Regulation Number
    870.4450
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The ITClamp™ is a trauma clamp device for the temporary control of severe bleeding in the extremities, axilla and inguinal areas.

    Device Description

    The ITClamp™ is a clamp device that quickly controls critical bleeding by closing the skin to create a temporary, contained hematoma until surgical repair. The ITClamp is a self-locking surgical clamp with suture needles that penetrate the skin to evert the skin edges between pressure bars of the device and anchor it to the skin to reduce slippage and leakage. Pressure is evenly distributed across the bars, which seal the skin over a wound. An adjustable locking mechanism increases or decreases pressure across the wound to achieve a fluid tight seal.

    The ITClamp™ controls bleeding by sealing the skin closed to apply direct pressure and create a temporary pool of blood (hematoma) under pressure. This permits formation of a stable clot until the patient can receive medical care and/or surgical repair.

    The device is provided sterile and is for single use.

    The ITClamp™ consists of the following components:

    1. Suture needles
    2. Plastic Shell
    3. Locking mechanism
    4. Lock release mechanism
    AI/ML Overview

    This document is a 510(k) summary for the iTClamp™ device. It primarily focuses on demonstrating substantial equivalence to a predicate device rather than presenting a detailed study with specific acceptance criteria and performance metrics typically seen for AI/ML-based devices. As such, many of the requested fields are not applicable or cannot be extracted from this type of document.

    Here's an analysis based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance CriteriaReported Device Performance
    Biocompatibility: Meet ISO 10993 standards (cytotoxicity, acute system toxicity, muscle implantation, pyrogenicity).Results confirmed that the materials used in the iTClamp™ are safe for its intended use.
    Bench Performance: Verify suitability of design characteristics for Extreme Temperature Evaluation, Tensile and Compression Test, Torque, and Needle (Bend and Pull).Results of the testing confirmed the iTClamp™ met design requirements.
    Animal Performance (Efficacy): Statistically significant improvements in survival, survival time, and blood loss in a lethal junctional bleed model compared to controls or standard gauze packing.The iTClamp™ resulted in statistically significant improvements in survival, survival time, and blood loss when compared with controls or packing with standard gauze.
    Tissue Damage (Safety): No tissue damage observed by histological examination after 3 hours of application in an animal model.Tissue damage was not observed by histological examination after 3 hours of application.
    Distribution/Aging/Packaging Integrity: Maintain product integrity for intended use through Distribution Challenge Testing, Accelerated Aging Studies, and microbial aerosol testing.All testing performed resulted in no nonconformance(s).

    2. Sample Size Used for the Test Set and Data Provenance

    The document describes an animal study (porcine model) for performance testing.

    • Sample Size: Not explicitly stated for the animal study.
    • Data Provenance: Porcine (animal model). The study was prospective in nature, as it involved conducting experiments to assess the device's performance.

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications

    • Not Applicable. This document describes a medical device (a clamp) and its physical and biological performance, not an AI/ML diagnostic or predictive device where expert-established ground truth for a test set would typically be required in the context of image or data interpretation. The ground truth for the animal study's outcomes (survival, blood loss, tissue damage) would be established through direct observation, measurement, and histological analysis by veterinary and scientific personnel, not human "experts" in the context of interpreting data for an algorithm.

    4. Adjudication Method for the Test Set

    • Not Applicable. As above, this is not an AI/ML-based device where adjudication of interpretations would be relevant. The outcomes of the animal study are objective measurements.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    • No. This is not an AI/ML-based device, so an MRMC study comparing human readers with and without AI assistance is not applicable.

    6. Standalone (Algorithm Only) Performance Study

    • No. This is a physical medical device, not an algorithm, so a standalone algorithm performance study is not applicable.

    7. Type of Ground Truth Used

    • For the animal study, the ground truth was outcomes data (survival, survival time, blood loss) and histology (for tissue damage assessment).
    • For biocompatibility, the ground truth was established by adherence to ISO 10993 standards and the results of specific assays (cytotoxicity, etc.).
    • For bench performance and packaging, the ground truth was established by design requirements and engineering specifications.

    8. Sample Size for the Training Set

    • Not Applicable. This is a physical medical device, not an AI/ML model, so the concept of a "training set" is not relevant.

    9. How the Ground Truth for the Training Set Was Established

    • Not Applicable. As above, the concept of a "training set" for an AI/ML model does not apply here.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1